Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zenapax in Cardiac Transplantation
NCT00048165Phase 4Completed
- Sponsor
- Roche
- Start
- Aug 1999
- Primary completion
- Aug 2002
- Modality
- Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 4 trial of daclizumab in heart transplant rejection, sponsored by Roche. Started Aug 1999; status: completed.
02
Drugs
daclizumab
03
Conditions
heart transplant rejection
Beyond the preview
Go deeper on NCT00048165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00048165.